Skip to main content
Clinical Trials/NCT04302597
NCT04302597
Completed
Not Applicable

Cosmetic Outcomes After Skin Closure of Pfannenstiel Incision With Tissue Adhesive (2-octylcyanoacrylate) or Staples in Repeated Cesarean Section

Università degli Studi dell'Insubria1 site in 1 country80 target enrollmentStarted: May 15, 2020Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Università degli Studi dell'Insubria
Enrollment
80
Locations
1
Primary Endpoint
Observer Scar Assessment Scale (OSAS) score

Overview

Brief Summary

Recent clinical trials were developed to test the outcomes of skin closure with tissue adhesive, staples and monofilament synthetic suture after cesarean section with Pfannenstiel incision: both clinical outcomes such as blood loss, surgical site infection, length of postpartum hospitalization, or wound disruption, as well as Patient and Observer Scar Assessment Scale (POSAS) scores 8 weeks after surgery, were comparable between these different skin closure methods.

Despite the available studies are often based on robust methodologies and appropriate assessment scales, most of them were aimed to evaluate cosmetic outcomes in primary cesarean section, whereas data analyses published so far do not allow to draw a firm conclusion about repeated cesarean sections. Based on these elements, the aim of this study is to evaluate cosmetic outcomes after skin closure of Pfannenstiel incision with tissue adhesive or staples in a selected population undergoing repeated cesarean section.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Previous cesarean section with Pfannenstiel incision (regardless of the indication, emergency/urgency, weeks of pregnancy and years passed from the previous cesarean section)
  • Maternal age 18-45 years
  • Singleton pregnancy at 37-41 weeks of gestation (based on first-trimester ultrasound) with a viable fetus

Exclusion Criteria

  • History of keloids
  • Previous transversal suprapubic scars
  • Clinical signs of infection and/or tattoos in the area to be studied
  • Known patient hypersensitivity to any of the suture materials used in the protocol
  • BMI below 20 or above 30
  • Any medical disorder that could affect wound healing, including severe malnutrition, conditions requiring chronic corticosteroid use or immune suppressant, uncontrolled diabetes mellitus (defined as Hemoglobin A1c \> 6%, unbalanced daily glucose measurements, and fasting glucose \>95 mg/dL).

Outcomes

Primary Outcomes

Observer Scar Assessment Scale (OSAS) score

Time Frame: 6 months after repeated cesarean section

The Observer Scar Assessment Scale (OSAS) rates 5 variables: vascularity, pigmentation, thickness, relief, and pliability. Each variable uses a 10-point scoring system, with 1 representing normal skin. Ratings of individual variables may be summed to obtain a total score ranging from 5-50, with 5 representing normal skin.

Secondary Outcomes

  • Patient Scar Assessment Scale (PSAS) score(6 months after repeated cesarean section)

Investigators

Sponsor
Università degli Studi dell'Insubria
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Antonio Simone Laganà

Principal Investigator

Università degli Studi dell'Insubria

Study Sites (1)

Loading locations...

Similar Trials